Blog

Welcome to The Happy Lungs Project Blog. Check out these blog posts from our Scientific Advisory Board members and other partners from the scientific community explaining the latest RET research.

We seek to support researchers and clinicians in their work toward a cure for Non-Small Cell Lung Cancer caused by the RET mutation. We also aim to provide community resources and events to support finding a cure for RET-Positive lung cancer. On this blog, you will find information about our research, RET clinical trials, patient stories and upcoming events.

We would like to also welcome our guest blogger, Anthony “Nino” Sireci, M.D., vice president, clinical biomarker and diagnostics development at Lilly. Read Nino’s News.

Filter

Dr Sarah Waliany RET + lung cancer research RETgistry
New Global Findings from the RETgistry: Advancing Care for RET-Altered Cancers

New Global Findings from the RETgistry: Advancing Care for RET-Altered Cancers

The RETgistry study looked at tumor samples from biopsies of RET patients whose cancers stopped…
April 7, 2026
lung cancer community
The Future of RET Therapy for NSCLC (2026 TTLC Meeting)

The Future of RET Therapy for NSCLC (2026 TTLC Meeting)

The IASLC 2026 Targeted Therapies of Lung Cancer (TTLC) Meeting was held on February 18th. The meeting…
March 26, 2026
ret lung cancer questions and answers
Q&A from the 2025 RET Lung Cancer Annual Webinar

Q&A from the 2025 RET Lung Cancer Annual Webinar

Expert answers to your most pressing questions about RET-positive cancer from our scientists and pharmaceutical…
March 24, 2026
Lilly pharmaceutical clinical trial
Positive Results for Selpercatinib for Early Stage-RET Lung Cancer

Positive Results for Selpercatinib for Early Stage-RET Lung Cancer

Eli Lilly and Company announced positive results from the Phase 3 LIBRETTO-432 clinical trial evaluating…
February 17, 2026
ret lung cancer oncologist newsletter archives
Finding the Right RET Oncologist for Your Cancer Treatment

Finding the Right RET Oncologist for Your Cancer Treatment

Finding the right oncologist and medical care team is one of the most important decisions…
February 13, 2026
2025 ret cancer research update
2025 RET Cancer Research Update

2025 RET Cancer Research Update

Your investment in The Happy Lungs Project has resulted in very exciting RET lung cancer…
December 19, 2025
lung cancer treatment research biomarker testing
The Role of Biomarker Testing in Early-Stage NSCLC: Why It’s Not Just for Advanced Disease

The Role of Biomarker Testing in Early-Stage NSCLC: Why It’s Not Just for Advanced Disease

Advances in biomarker science are reshaping how patients are diagnosed with and manage early-stage lung…
December 15, 2025
2025 RET Research Update with Pharma sponsors
2025 RET Webinar: Meet Our Speakers

2025 RET Webinar: Meet Our Speakers

The 2025 RET Research Update is just around the corner, and we are excited to…
October 27, 2025
POISE cancer study
Join the POISE study at Massachusetts General Hospital

Join the POISE study at Massachusetts General Hospital

Join the study! Researchers have developed POISE, a short program combining palliative and survivorship care…
October 23, 2025
IASLC ret cancer highlights 2025
RET Studies Presented at the IASLC 2025 World Conference on Lung Cancer

RET Studies Presented at the IASLC 2025 World Conference on Lung Cancer

The 2025 IASLC World Conference on Lung Cancer was held in Barcelona, Spain, from September…
September 12, 2025
lung cancer genetic study database
Announcing the Lung Cancer Genetics Study Database

Announcing the Lung Cancer Genetics Study Database

A cancer diagnosis can be life-altering but with access to high-quality, compassionate care, patients can…
September 11, 2025
cancer and home health care services
Home Health Care: Bringing Cancer Care Home

Home Health Care: Bringing Cancer Care Home

A cancer diagnosis can be life-altering but with access to high-quality, compassionate care, patients can…
August 11, 2025
RET clinical study phase 2 ellipses
Ellipses’ RET inhibitor EP0031 advances to Phase 2 clinical trials

Ellipses’ RET inhibitor EP0031 advances to Phase 2 clinical trials

Ellipses’ next generation selective RET inhibitor EP0031 advances to Phase 2 clinical trials in the…
July 10, 2025
2025 ASCO meeting
RET Highlights Presented at the 2025 American Society of Clinical Oncology (ASCO)

RET Highlights Presented at the 2025 American Society of Clinical Oncology (ASCO)

RET Highlights Presented at the 2025 American Association for Cancer Research (AACR)
July 2, 2025
2025 AACR ret cancer
RET Highlights Presented at the 2025 American Association for Cancer Research (AACR)

RET Highlights Presented at the 2025 American Association for Cancer Research (AACR)

RET Highlights Presented at the 2025 American Association for Cancer Research (AACR)
May 29, 2025